SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-011219
Filing Date
2020-06-16
Accepted
2020-06-16 06:58:48
Documents
8
Period of Report
2020-06-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 32329
2 ex10-1.htm EX-10.1 3735
3 ex10-2.htm EX-10.2 325595
4 ex99-1.htm EX-99.1 17740
5 ex10-1_001.jpg GRAPHIC 168947
6 ex10-1_002.jpg GRAPHIC 165512
7 ex10-1_003.jpg GRAPHIC 51410
8 ex10-1_004.jpg GRAPHIC 52463
  Complete submission text file 0001493152-20-011219.txt   984637
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 20964960
SIC: 2834 Pharmaceutical Preparations